NUTRAMAX FY 11194 SALES ADVANCE 80% TO $55.9 MIL.
This article was originally published in The Tan Sheet
Executive Summary
NUTRAMAX FY 11194 SALES ADVANCE 80% TO $55.9 MIL. on a strong fourth quarter. Sales in the final quarter, ended Oct. 1, rose 78% to $15.4 mil. The company noted that feminine hygiene, infant care and cough/cold products each contributed more than 20% to total sales, with personal care and ophthalmic products contributing approximately 5% and 10%, respectively.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning